<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04812873</url>
  </required_header>
  <id_info>
    <org_study_id>JWP-FER-401</org_study_id>
    <nct_id>NCT04812873</nct_id>
  </id_info>
  <brief_title>Registry Study of ID &amp; IDA in Korean Patients With Heart Failure</brief_title>
  <acronym>HFRegistry</acronym>
  <official_title>The Prevalence of ID (Iron Deficiency) &amp; IDA (Iron Deficiency Anemia) in Korean Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JW Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>JW Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of Iron Deficiency and Iron Deficiency Anemia in Korean HF patient&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological study to assess The prevalence of ID (Iron Deficiency) &amp; IDA (Iron Deficiency&#xD;
      Anemia) in Korean patients with heart failure&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2019</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">November 12, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Prevalence of Iron Deficiency</measure>
    <time_frame>1 day</time_frame>
    <description>serum ferritin &lt; 100 ㎍/L or serum ferritin 100-299 ㎍/L and TSAT* &lt; 20%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Prevalence of Iron Deficiency Anemia</measure>
    <time_frame>1 day</time_frame>
    <description>include Iron Deficiency criteria &amp; Male: Hb &lt; 13 g/dL, Female Hb &lt; 12 g/dL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Current Anemia treatment</measure>
    <time_frame>1 day</time_frame>
    <description>Number of Participants take Anemia Medication</description>
  </secondary_outcome>
  <enrollment type="Actual">465</enrollment>
  <condition>Iron Deficiency Anemia</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Ferritin, Hb, Iron, TSAT BNP(or NT-proBNP), RDW, platelet, WBC, neutrophil count,&#xD;
      lymphocyte count&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Korean patients with heart failure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  more than 19 years old&#xD;
&#xD;
          -  Informed Consent Form&#xD;
&#xD;
          -  Hear Failure criteria as belows&#xD;
&#xD;
               -  Heart Failure Sign(more than 1 Sx such as fatigue, dyspnea, ankle swelling)&#xD;
&#xD;
                    -  Heart Failure Symptom(more than 1 among Jugular venous pressure (JVP)&#xD;
                       elevation, pulmonary crackle, peripheral edema) ③ Lung congestion or edema&#xD;
                       at chest X-ray ④ Objective findings of structural or functional cardiac&#xD;
                       abnormality(more than abnormality level of BNP or NT-proBNP, abnormality of&#xD;
                       echocardiography )&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not applicable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>SOOJIN JUN</last_name>
    <role>Study Director</role>
    <affiliation>JWPharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

